RecruitingNot Applicable

Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion

United States100 participantsStarted 2026-05-27

Plain-language summary

The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.

Who can participate

Age range

21 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age and Body Mass Index (BMI)
. Adult patients aged ≥ 21 years at screening.
. BMI ≤ 40.
. Chronic SIJ Related Pain
. Has experienced low back and/or buttock pain for at least 6 months that has been inadequately responsive to non surgical management.
. Has experienced nonradicular pain that is maximal below the L5 vertebrae, localized over the posterior SIJ, and consistent with SIJ pain.
. Diagnosis of SIJ Dysfunction
. Baseline Disability and Pain Severity

Exclusion criteria

. Pain Source Uncertainty
. Alternative Primary Spine Pathology
. Other Sacroiliac Pathology a. Presence of known sacroiliac joint pathology other than degenerative SIJ dysfunction, including inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA associated spondyloarthropathies), tumor, infection, acute fracture, or crystal arthropathy.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Composite safety and efficacy endpoint

Timeframe: Month 6

Trial details

NCT IDNCT07547215

SponsorPainTEQ, LLC

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-07

Contact for this trial

Lalit Venkatesan, PhD

18552487246 lalit.venkatesan@painteq.com

View on ClinicalTrials.gov More Sacroiliac Joint Dysfunction trials